本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

79.31
-1.8100-2.23%
盤後79.310.00000.00%19:30 EDT
成交量:49.08萬
成交額:3,924.40萬
市值:34.80億
市盈率:-73.27
高:83.23
開:82.27
低:79.18
收:81.12
52周最高:91.53
52周最低:48.20
股本:4,388.30萬
流通股本:3,267.99萬
量比:0.48
換手率:1.50%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
淨資產收益率:-13.68%
總資產收益率:-5.48%
市淨率:10.04
市盈率(LYR):-49.88

資料載入中...

2024/04/23

重要事件披露

Form 8-K - Current report
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals